The 5th BioPharma Supply Chain and Logistics Nexus takes place on October 22-23, 2024, at the Holiday Inn Piscataway – Somerset Hotel in New Jersey. It is a gathering of professionals and companies/vendors that deal with regulatory affairs, supply chain management, information technology and data analytics, logistics and distribution, compliance, transportation and distribution, procurement and purchasing, packaging and sustainability, warehouse and inventory control, manufacturing and operations, and cold chain management.

The two-day conference features educational presentations, panel discussions and roundtable discussions. Interrupting these sessions are plenty of networking opportunities during extended breaks and planned sessions, allowing attendees to interact with peers, distinguished speakers and professionals. And with past attendees expressing appreciation for the conference as a “great opportunity for exchange of ideas and network” and the perfect setting to learn about innovative solutions and engage with key players, the upcoming 5th BioPharma Supply Chain and Logistics Nexus is an event you cannot afford to miss.

It promises to be a pleasant learning opportunity for attendees, with the diversity of both the speakers and topics boosting the overall experience. The upcoming event is themed around “Linking the Chain: Future Logistics in BioPharma Progress.” The organizers, Nexus Conference, expand this theme into four main agenda streams along which speakers will align their talking points and presentations.

The four agenda streams include:

• external relationships & supply chain transparency
• transparent and sustainable cold chain
• revolutionizing strategic procurement and manufacturing innovation
• quality and compliance in supply chain: innovations for integration

All the promised valuable insights would, however, be impossible without the speakers. Accordingly, this year’s event features an expansive roster of leading voices in procurement, logistics, supply chain, serialization and product safety, product development and clinical supply, sourcing, quality assurance and quality control, product management, and more.

The speakers at the 5th BioPharma Supply Chain and Logistics Nexus include Anthony L. Colenburg Sr.,Senior Director and Site Head of Quality at Sutro BioPharma; Stephanie Jones, MBA, Senior Manager, Vendor Relationships Management at Gilead; Michael Mehler, Director of Cell Therapy Supply Chain and Operations at Takeda; Irena Maksimovic, Senior Director of Strategy and Business Operations – Clinical Supply Chain at BMS; Zofia Wrona, Associate Director and Global GxP Auditor at Cabaletta Bio; Matthew Lyke, MBA, Associate Director of Value Stream Planning at BMS; Gautum Pangu, Ph.D., PMP,  Associate Director of Biologics CMC Project Management at Incyte; and Humberto Vega, Global Head MSAT at J&J, just to mention a few.

The speakers will explore the key aspects of supply chain and logistics in the biopharmaceutical sector. They will delve into enhancing transparency and sustainability in temperature-controlled logistics, embracing innovative technologies in supply chain and logistics, de-risking operations, compliance, and forging collaborations. Additionally, they will highlight the challenges and opportunities for Contract Manufacturing Organizations (“CMOs”) and Contract Development and Manufacturing Organizations (“CDMOs”).

“Join us as we optimize and innovate the biopharma supply chain, fostering connections and excellence in logistics and operations,” Nexus Conference conveys.

To learn more, visit https://ibn.fm/klCVo

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN